These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 16147541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
    Tepavcević V, Blakemore WF.
    Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
    [Abstract] [Full Text] [Related]

  • 3. Transplantation options for therapeutic central nervous system remyelination.
    Blakemore WF, Franklin RJ.
    Cell Transplant; 2000 Dec; 9(2):289-94. PubMed ID: 10811401
    [Abstract] [Full Text] [Related]

  • 4. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS.
    Blakemore WF, Crang AJ, Franklin RJ, Tang K, Ryder S.
    Glia; 1995 Feb; 13(2):79-91. PubMed ID: 7649617
    [Abstract] [Full Text] [Related]

  • 5. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain.
    Targett MP, Sussman J, Scolding N, O'Leary MT, Compston DA, Blakemore WF.
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):199-206. PubMed ID: 8804021
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination.
    van Engelen BG, Pavelko KD, Rodriguez M.
    Mult Scler; 1997 Apr; 3(2):76-9. PubMed ID: 9291157
    [Abstract] [Full Text] [Related]

  • 7. The DTA Mouse Model for Oligodendrocyte Ablation and CNS Demyelination.
    Traka M.
    Methods Mol Biol; 2019 Apr; 1936():295-310. PubMed ID: 30820906
    [Abstract] [Full Text] [Related]

  • 8. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors.
    Blakemore WF, Gilson JM, Crang AJ.
    Exp Neurol; 2003 Dec; 184(2):955-63. PubMed ID: 14769388
    [Abstract] [Full Text] [Related]

  • 9. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells.
    Groves AK, Barnett SC, Franklin RJ, Crang AJ, Mayer M, Blakemore WF, Noble M.
    Nature; 1993 Apr 01; 362(6419):453-5. PubMed ID: 8464477
    [Abstract] [Full Text] [Related]

  • 10. Adaptive human immunity drives remyelination in a mouse model of demyelination.
    El Behi M, Sanson C, Bachelin C, Guillot-Noël L, Fransson J, Stankoff B, Maillart E, Sarrazin N, Guillemot V, Abdi H, Cournu-Rebeix I, Fontaine B, Zujovic V.
    Brain; 2017 Apr 01; 140(4):967-980. PubMed ID: 28334918
    [Abstract] [Full Text] [Related]

  • 11. Cellular approaches for stimulating CNS remyelination.
    Miller RH, Bai L.
    Regen Med; 2007 Sep 01; 2(5):817-29. PubMed ID: 17907933
    [Abstract] [Full Text] [Related]

  • 12. Repair of myelin disease: strategies and progress in animal models.
    Duncan ID, Grever WE, Zhang SC.
    Mol Med Today; 1997 Dec 01; 3(12):554-61. PubMed ID: 9449127
    [Abstract] [Full Text] [Related]

  • 13. New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation.
    Chari DM, Blakemore WF.
    Mult Scler; 2002 Aug 01; 8(4):271-7. PubMed ID: 12166495
    [Abstract] [Full Text] [Related]

  • 14. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.
    Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ.
    Mol Cell Neurosci; 2004 Feb 01; 25(2):252-62. PubMed ID: 15019942
    [Abstract] [Full Text] [Related]

  • 15. The effect of immunosuppressive protocols on spontaneous CNS remyelination following toxin-induced demyelination.
    Smith PM, Franklin RJ.
    J Neuroimmunol; 2001 Oct 01; 119(2):261-8. PubMed ID: 11585629
    [Abstract] [Full Text] [Related]

  • 16. Remyelination of the demyelinated CNS: the case for and against transplantation of central, peripheral and olfactory glia.
    Franklin RJ.
    Brain Res Bull; 2002 Apr 01; 57(6):827-32. PubMed ID: 12031280
    [Abstract] [Full Text] [Related]

  • 17. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
    Crang AJ, Gilson JM, Li WW, Blakemore WF.
    Eur J Neurosci; 2004 Sep 01; 20(6):1445-60. PubMed ID: 15355312
    [Abstract] [Full Text] [Related]

  • 18. Early netrin-1 expression impairs central nervous system remyelination.
    Tepavčević V, Kerninon C, Aigrot MS, Meppiel E, Mozafari S, Arnould-Laurent R, Ravassard P, Kennedy TE, Nait-Oumesmar B, Lubetzki C.
    Ann Neurol; 2014 Aug 01; 76(2):252-68. PubMed ID: 24942777
    [Abstract] [Full Text] [Related]

  • 19. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE, Kuhlmann T, Antel JP.
    Biochim Biophys Acta; 2011 Feb 01; 1812(2):184-93. PubMed ID: 20887785
    [Abstract] [Full Text] [Related]

  • 20. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK, Blakemore WF.
    Brain; 2005 Mar 01; 128(Pt 3):528-39. PubMed ID: 15699059
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.